Speaker(s): 

M. Amer Swid, MD, Resident Physician, Geisinger - has nothing to disclose.

Haluk Kavus, MD, Resident Physician, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Pathology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Review the current guidelines and HER2 scoring criteria for salivary duct carcinoma

• Analyze the clinical implication of HER2 expression and ERBB2 amplification salivary duct carcinoma

• Recommend a practical approach to diagnose of MDS

• Describe molecular and morphological subtypes of MDS

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary S. Hoffer, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session: 

None.